Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Chan

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor marginsMatthew M Grabowski, Dionysios C Watson, Kunho Chung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2008
High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilitiesJohn Wong, Elwood Armour, Peter Kazanzides, et al.
Neuro-Oncology|April 28, 2016
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expressionXiaoran Zhang, Aparana Rao, Paola Sette, et al.
Circulation Research|April 15, 2021
COVID-19 and Cardiovascular Disease: From Bench to BedsideMina K Chung, David A Zidar, Michael R Bristow, et al.
Communications Medicine|May 17, 2025
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypesAvia D Wilkerson, Ivan Juric, Salendra Singh, et al.
Chemrxiv : the Preprint Server for Chemistry|July 18, 2020
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Plos Biology|November 6, 2020
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2017
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor VirulenceTihana Ibrahimpasic, Bin Xu, Iñigo Landa, et al.
Science Immunology|May 17, 2024
LRIG1 engages ligand VISTA and impairs tumor-specific CD8<sup>+</sup> T cell responsesHieu Minh Ta, Dia Roy, Keman Zhang, et al.
Research Square|June 19, 2023
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic SarcomaEashwar Somasundaram, Timothy D Smile, Ahmed Halima, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor marginsMatthew M Grabowski, Dionysios C Watson, Kunho Chung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2008
High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilitiesJohn Wong, Elwood Armour, Peter Kazanzides, et al.
Neuro-Oncology|April 28, 2016
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expressionXiaoran Zhang, Aparana Rao, Paola Sette, et al.
Circulation Research|April 15, 2021
COVID-19 and Cardiovascular Disease: From Bench to BedsideMina K Chung, David A Zidar, Michael R Bristow, et al.
Communications Medicine|May 17, 2025
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypesAvia D Wilkerson, Ivan Juric, Salendra Singh, et al.
Chemrxiv : the Preprint Server for Chemistry|July 18, 2020
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Plos Biology|November 6, 2020
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2017
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor VirulenceTihana Ibrahimpasic, Bin Xu, Iñigo Landa, et al.
Science Immunology|May 17, 2024
LRIG1 engages ligand VISTA and impairs tumor-specific CD8<sup>+</sup> T cell responsesHieu Minh Ta, Dia Roy, Keman Zhang, et al.
Research Square|June 19, 2023
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic SarcomaEashwar Somasundaram, Timothy D Smile, Ahmed Halima, et al.
Pageof 5